# Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

> **NCT00005785** · PHASE1 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 30 (—)

## Conditions studied

- Hematologic Neoplasm
- HIV Infection

## Interventions

- **DRUG:** GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV

## Key facts

- **NCT ID:** NCT00005785
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2001-11
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005785, "Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*